Monte Rosa Therapeutics
GLUE
#7469
Rank
A$0.48 B
Marketcap
$7.69
Share price
-2.17%
Change (1 day)
-10.44%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2023 (TTM): -$3.86

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.99. In 2022 the company made an earnings per share (EPS) of -$3.56 an increase over its 2021 EPS that were of -$7.54.

EPS history for Monte Rosa Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.868.35%
2022-$3.56-52.81%
2021-$7.54193.97%
2020-$2.57